HTL Clinical

HTL Clinical is a full-service histopathology contract research organization (CRO) operating in Boulder, Colorado. The company is a relatively new venture, having been formed from the success of HistoTox Labs, a longstanding non-clinical CRO. With 20-49 employees, HTL Clinical occupies a newly renovated 16,200 square foot facility. HTL Clinical provides medically relevant non-clinical and clinical services to pharmaceutical, biotech, and academic clients. Their expertise centers around providing high quality histology, pathology, digital pathology, and immunohistochemistry (IHC) services. The company is renowned for its extensive library of optimized antibodies, supported by a team of highly trained scientific staff. In addition to IHC services, HTL Clinical offers cutting-edge imaging technology, including Aperio AT2 high-throughput slide scanners, fluorescent whole-slide scanners, and Visiopharm image analysis software. Their team of experts is comprised of board-certified MD and DVM pathologists, trained histotechnicians, scientists, project managers, and hands-on upper management. HTL Clinical is dedicated to providing substantiated expertise in clinical trial services and laboratory diagnostics, aiding in data-driven decision making within the oncology field. For more information about HTL Clinical's services and capabilities, please visit their website at htlclinical.com.